Skip to main content
SpringerLink
Log in

Oestrogens and Thrombosis

  • Conference paper
HRT and Osteoporosis

Abstract

There are a number of uncertainties and anomalies about the effects of oestrogens on thrombogenic pathways and thus on the incidence of clinical events that are due largely or partly to thrombosis — primarily ischaemic heart disease (IHD) and stroke. This chapter summarises the evidence on associations between oestrogen levels and thrombotic episodes and the apparent effects of these levels on thrombogenic mechanisms. It may be possible to resolve some of the anomalies observed, as least in part, by considering mechanisms protecting against thrombosis, as well as in those leading to it.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vickers MV, Thompson SG. Sources of variability in dose response platelet aggregometry. Thromb Haemost 1985; 53:216–20.

    PubMed  Google Scholar 

  2. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines, AP, Miller GJ. Epidemiological characteristics of platelet aggregability. Br Med J 1985; 290:428–32.

    Article  CAS  Google Scholar 

  3. Meade TW, Vickers MV, Thompson SG, Seghatchian MJ. The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res 1985; 38:527–34.

    Article  PubMed  CAS  Google Scholar 

  4. Meade TW. The epidemiology of haemostatic and other variables in coronary artery disease. In: Verstraete M, Vermylen J, Lijnen R, Arnout J, eds. Thrombosis and Haemostasis. Leuven: Leuven University Press, 1987; 37–60.

    Google Scholar 

  5. Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. JAMA 1987; 258:1183–6.

    Article  PubMed  CAS  Google Scholar 

  6. Vessey MP, Villard-Mackintosh L, McPherson K, Yeates D. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. Br Med J 1989; 299:1487–91.

    Article  CAS  Google Scholar 

  7. Inman WHW, Vessey MP, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J 1970; 2:203–9.

    Article  PubMed  CAS  Google Scholar 

  8. Royal College of General Practitioners. Oral contraceptives and health. London, Royal College of General Practitioners, 1974.

    Google Scholar 

  9. Meade TW, Greenberg G, Thompson SG. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50 and 30 μg oestrogen preparations. Br Med J 1980; i:1157–61.

    Article  Google Scholar 

  10. Kay CR. Progestogens and arterial disease — evidence from the Royal College of General Practitioners’ study. Am J Obstet Gynecol 1982; 142:762–5.

    PubMed  CAS  Google Scholar 

  11. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979; i:153–6.

    Article  Google Scholar 

  12. Bradley DD, Wingerd J, Petitti DB, Krauss RM, Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med 1978; 299:17–20.

    Article  PubMed  CAS  Google Scholar 

  13. Khaw K-T, Peart WS. Blood pressure and contraceptive use. Br Med J 1982; 285:403–7.

    Article  CAS  Google Scholar 

  14. Stan well-Smith R, Meade TW. Hormone replacement therapy for menopausal women: a review of its effect on haemostatic function, lipids, and blood pressure. Adv Drug React Ac Pois Rev 1984;4:187–210.

    Google Scholar 

  15. Meade TW, Dyer S, Howarth DJ, Imeson JD, Stirling Y. Antithrombin III and procoagulant activity: sex differences and effects of the menopause. Br J Haematol 1990; 74:77–81.

    Article  PubMed  CAS  Google Scholar 

  16. Meade TW. Epidemiology of atheroma, thrombosis and ischaemic heart disease. In: Bloom AL, Thomas DP, eds. Haemostasis and Thrombosis, 2nd ed. Edinburgh, Churchill Livingstone, 1987; 697–720.

    Google Scholar 

  17. Vessey M, Hunt K. The menopause, hormone replacement therapy and cardiovascular disease: epidemiological aspects. In: Studd J, Whitehead MI, eds. The menopause. Oxford, Blackwell Scientific Publications, 1988; 190–6.

    Google Scholar 

  18. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988; 115:954–63.

    Article  PubMed  CAS  Google Scholar 

  19. Sullivan JM, Vander Zwaag R et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988; 108:358–63.

    PubMed  CAS  Google Scholar 

  20. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J 1988; 297:519–22.

    Article  CAS  Google Scholar 

  21. Armitage P. Clinical trial in the secondary prevention of myocardial infarction and stroke. Thromb Haemost 1980; 43:90–4.

    PubMed  CAS  Google Scholar 

  22. Thompson SG, Meade TW, Greenberg G. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. J Epidemiol Community Health 1989; 43:173–8.

    Article  PubMed  CAS  Google Scholar 

  23. Meade TW, Haines AP, Imeson JD, Stirling Y, Thompson SG. Menopausal status and haemostatic variables. Lancet 1983; i:22–4.

    Article  Google Scholar 

  24. Scarabin PY, Bonithon-Kopp C, Bara L, Malmejac A, Guize L, Samama M. Increased factor VII reactivity in menopausal women. Thromb Haemost 1989; 62:56.

    Google Scholar 

  25. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321:641–6.

    Article  PubMed  CAS  Google Scholar 

  26. Henriksson P, Edhag O. Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. Br Med J 1986; 293:413–15.

    Article  CAS  Google Scholar 

  27. Henriksson P, Blomback M, Bratt G, Edhag O, Eriksson A. Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy. Thromb Res 1986; 44:783–91.

    Article  PubMed  CAS  Google Scholar 

  28. Meilahn E, Kuller LH, Kiss JE, Matthews KA, Lewis JH. Coagulation parameters among pre-and postmenopausal women. Am J Epidemiol 1988; 128:908.

    Google Scholar 

  29. Vessey MP, Villard-Mackintosh L, McPherson K, Yeates D. Mortality among oral contraceptive users: 20 years follow-up of women in a cohort study. Br Med J 1989; 299:1487–91.

    Article  CAS  Google Scholar 

  30. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 1988; 319:1313–17.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. T. W. Meade
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clarendon Wing, Leeds General Infirmary, Leeds, LS1 3EX, UK

    James O. Drife MD, FRCS Ed, FRCOG (Professor of Obstetrics and Gynaecology) (Professor of Obstetrics and Gynaecology)

  2. King’s College Hospital, London, SE5 9RS, UK

    John W. W. Studd MD, BS, FRCOG (Consultant Obstetrician and Gynaecologist, Director) (Consultant Obstetrician and Gynaecologist, Director)

  3. The Menopause Clinic, Dulwich Hospital, East Dulwich Grove, London, SE22 8PT, UK

    John W. W. Studd MD, BS, FRCOG (Consultant Obstetrician and Gynaecologist, Director) (Consultant Obstetrician and Gynaecologist, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag London Limited

About this paper

Cite this paper

Meade, T.W. (1990). Oestrogens and Thrombosis. In: Drife, J.O., Studd, J.W.W. (eds) HRT and Osteoporosis. Springer, London. https://doi.org/10.1007/978-1-4471-1799-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1799-5_18

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1801-5

  • Online ISBN: 978-1-4471-1799-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation